Healthcare represents one fifth of the U.S. economy, a complex of industries encompassing everything from patient care to information technology and real estate. Where should we be looking for innovations that can both improve care and reduce costs across this massive system? Experts in patient care, IT, architecture, and pharmaceuticals discuss the innovations on the horizon. When: January 22, 12-1pm EST Listen to a Recording: https://www.youtube.com/watch?v=Ig9-m8i1rIk Moderator: Richard Foster, Lecturer in Management, Yale School of Management Dr. Foster is an emeritus director of McKinsey & Company, Inc. At McKinsey Dr. Foster was a Director and Senior Partner. While at McKinsey he founded several practices including the healthcare practice and the private equity practices, the technology practice and innovation practice. From 1995 to 1998 he led McKinsey's worldwide knowledge development. At Yale, Dr. Foster teaches "Managing In Times of Rapid Change" and serves as the Executive in Residence at the Yale Entrepreneurial Institute. Dr. Foster's research interests are in the relationships between capital formation, innovation, and regulation. Dr. Foster has written two best-selling books: Innovation: The Attacker's Advantage (1986) and Creative Destruction (2001), both of which were cited as among the "ten best books of the year" when they were published by the Harvard Business Review. Innovation: The Attacker's Advantage was voted by CEO surveyed by the Wall Street Journal as one of the five best books of the year. Dr. Foster's work has also appeared in Business Week, the Wall Street Journal, the New York Times as well as several dozen articles in research and popular journals. In 2012 "Creative Destruction" was cited by the Harvard Business Review as one of the "Great Moments in Management" in the past century. Dr. Foster was also recognized as one of their ten "Masters of Innovation" in the past century. Dr. Foster was the external leader of the Council on Foreign Relations Study Group on Innovation and Economic Power which led to the publication of Technological Innovation and Economic Performance, Princeton University Press (2001). Dr. Foster is also a special advisor to Yale's President on Healthcare Innovation and an Executive in Residence at the Yale Entrepreneurial Institute. Panelists: Michael Apkon '02, President and CEO of The Hospital for Sick Children Dr. Apkon is a physician executive and paediatric specialist serving in senior leadership roles at several top academic hospitals. He has served as the CEO at SickKids, since January 2014. In that capacity, he leads a 300 bed hospital staffed by 10,000 employees, scientists, medical staff, students and volunteers with a $1 BB budget. SickKids is recognized as one of the world's top children's hospitals and a highly successful clinical, educational, and research organization. Prior to coming to SickKids, Dr. Apkon was Senior Vice President for Medical Affairs and the Chief Medical Officer for the Children's Hospital of Philadelphia (CHOP) and Professor of Anesthesiology and Critical Care at the University of Pennsylvania as well as a practicing Paediatric Intensive Care specialist. Dr. Apkon also served in leadership roles at Yale University School of Medicine and Yale-New Haven Health System including being the Executive Director leading Yale-New Haven Children's Hospital as well as serving on the faculty of Yale School of Medicine and the Yale School of Management. Dr. Apkon has a BSc degree in Biomedical Engineering from Northwestern University as well as MD and PhD degrees from Washington University School of Medicine in St. Louis and an MBA from the Yale School of Management. As a healthcare executive, Dr. Apkon has led systems development and improvement to drive high quality and safe care, improve clinical operations, and promote an integrated approach to healthcare across a continuum of services. Academic interests relate to the use of Technology to enhance safety, and the application of operations management tools to enhance performance. Rosalyn Cama, President and Principal Interior Designer, CAMA, Inc. Rosalyn Cama is President and Principal Interior Designer of CAMA, Inc. in New Haven, Connecticut. An interior planning and design firm steeped in evidence-base design, the firm's mission is to create interior environments that improve outcomes. Roz has been a practicing healthcare designer for 30 years, and has worked on projects throughout the United States, including Yale-New Haven Hospital, Baystate Health System, Dublin Methodist Hospital of OhioHealth, The American Cancer Society and Hope Lodge and the University Medical Center at Princeton. A fellow of the American Society of Interior Designers (ASID), Roz has served as the chair of its Healthcare Specialty Network and is a past National President. She is also a recipient of many design and service awards, including an Honorary Doctorate in Fine Arts from the New York School of Interior Design in 2014 and the ASID Designer of Distinction award in 2012. Roz is a frequent speaker about evidence-based healthcare design at meetings and conventions internationally. She has also written and published numerous articles on the subject. Her latest book publication is titled, "Evidence-Based Healthcare Design" (John Wiley & Sons in association with the American Society of Interior Designers, 2009). Bryan Kim '00, Head of Strategy & Marketing for Biosimilars, Boehringer Ingelheim Bryan Kim is currently the head of strategy & marketing for the biosimilars business at Boehringer Ingelheim. Previously, he held various marketing and sales roles at Pfizer, and led client engagements as a management consultant with Booz & Co. Bryan is currently based out of Frankfurt, Germany. Michael Sherling '02, Chief Medical Officer & Co-founder, Modernizing Medicine Dr. Michael Sherling is the Chief Medical Officer and Co-founder of Modernizing Medicine, Inc., a healthcare IT company that is revolutionizing the way in which medical information is created, consumed and utilized to increase efficiency, lower costs and improve outcomes. Founded in February 2010, Modernizing Medicine has grown to over 200 employees and has raised over $45M in funding. Known for its progressive growth as a medical technology company, the company was named as a 2014 Red Herring North America award winner. In the same year the U.S. Chamber of Commerce named Modernizing Medicine the Small Business of the Year Regional Finalist, and honored Michael and CEO and co-founder Dan Cane with the Leadership in Health Care Award. Modernizing Medicine was in the top 50 of America's Most Promising Companies in 2013 by Forbes. The company was recognized by the Florida Business Journals as third on the list of the 100 Fastest Growing Companies in the State of Florida in 2013. In the same year, the South Florida Business Journal named Modernizing Medicine the #1 Fastest Growing Company in the Fast 50 for the second consecutive year and selected the company as one of The Best Places to Work. The South Florida Business Journal selected Modernizing Medicine as the Business of the Year in 2012. Michael is responsible for developing and designing the dermatology-based software, and supervising the medical arm of ophthalmology, orthopedics, plastic and cosmetic surgery, otolaryngology, gastroenterology, rheumatology and urology software. Michael obtained his BS in Biology at Brown University with honors in 1996, his MD from Yale School of Medicine with honors in 2002, and his MBA from Yale School of Management in 2002. He received his clinical training at Harvard Medical School, where he served as chief resident in dermatology and was the youngest physician to serve as the Associate Residency Program Director for Harvard Medical School's Department of Dermatology. He also completed a laser and cosmetic fellowship with Dr. Rox Anderson at the Wellman Center for Photomedicine.